Skip to main content
Ananda Pharma Plc logo

Ananda Pharma Plc — Investor Relations & Filings

Ticker · ANAN ISIN · GB00BDQPXQ60 LEI · 894500DFM8VOC5FW4X47 Aquis Stock Exchange Manufacturing
Open in API
Filings indexed 196 across all filing types
Latest filing 2021-02-26 Regulatory Filings
Country GB United Kingdom
Listing Aquis Stock Exchange ANAN

About Ananda Pharma Plc

https://www.anandapharma.co.uk/

Ananda Pharma Plc is a biopharmaceutical company focused on the development of regulatory-approved, cannabinoid-based medicines. The company's primary mission is to create therapies for complex, chronic inflammatory conditions with significant unmet medical needs. Its development pipeline is initially centered on treatments for inflammatory pain conditions, including Chemotherapy-Induced Peripheral Neuropathy (CIPN) and endometriosis, as well as heart failure with preserved ejection fraction (HFpEF). Ananda Pharma's approach covers the full development cycle, from identifying clinical potential and optimizing drug candidates to conducting clinical trials and securing marketing authorizations from regulators.

Recent filings

Filing Released Lang Actions
Ananda Developments Plc - Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is a formal announcement regarding 'Total Voting Rights' in accordance with the Financial Conduct Authority's Disclosure and Transparency Rules. It specifies the total number of ordinary shares and voting rights, which is a standard regulatory disclosure requirement for listed companies. Since it does not fit into specific categories like 'Major Shareholding Notification' (which tracks individual investor thresholds) or 'Declaration of Voting Results' (which reports outcomes of specific meetings), it falls under the general regulatory filing category.
2021-02-26 English
Ananda Developments Plc - Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a formal notification of major shareholdings, specifically containing two 'TR-1: Standard form for notification of major holdings' filings. These forms are used to report when a shareholder's interest in a company crosses a specific threshold. This falls directly under the definition of a 'Major Shareholding Notification'.
2021-02-22 English
Ananda Developments Plc - £300,000 raised for medicinal cannabis growing strategy
Share Issue/Capital Change Classification · 100% confidence The document is an announcement by Ananda Developments Plc regarding a £300,000 capital raise through a subscription for new ordinary shares. It details the purpose of the funds (medicinal cannabis growing facility), the issuance of warrants, and the resulting change in total voting rights. This falls under the category of share issuance and capital changes, which is specifically defined as 'SHA'.
2021-02-15 English
Ananda Developments Plc - Shareholder Update
Regulatory Filings Classification · 95% confidence The document is a 'Shareholder Update' issued by Ananda Developments Plc. It provides a narrative update on the company's business operations, specifically regarding its medicinal cannabis cultivation license application, market sector growth, and status of other investments. It does not contain formal financial statements, audit results, or proxy voting materials. It functions as a general corporate update to shareholders and the market, which falls under the 'Regulatory Filings' (RNS) category as it is a standard announcement disseminated via a Regulatory Information Service.
2021-02-11 English
Ananda Developments Plc - Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is a formal announcement regarding 'Total Voting Rights' issued by Ananda Developments Plc in accordance with the FCA's Disclosure and Transparency Rules. It provides the total number of shares and voting rights to assist shareholders with regulatory notifications. This type of disclosure is a standard regulatory requirement for listed companies and does not fit into specific categories like dividends, M&A, or financial reports. Therefore, it is classified as a general regulatory filing.
2020-11-30 English
Ananda Developments Plc - Exercise of Warrants and Grant of Options
Director's Dealing Classification · 98% confidence The document details the exercise of warrants and the grant of share options by directors and persons discharging managerial responsibilities (PDMRs) at Ananda Developments Plc. It includes mandatory PDMR transaction disclosure tables as required by the Market Abuse Regulation (MAR). While it mentions share capital changes, the primary purpose and the bulk of the content are the disclosures of insider dealings and director-related transactions, which aligns perfectly with the 'Director's Dealing' (DIRS) category.
2020-11-11 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.